Neovacs and Centurion sign licence agreement for lupus treatment IFNalpha Kinoid in Turkey

French biotechnology company Neovacs has signed an exclusive licence agreement with Centurion Pharma for IFNalpha Kinoid to treat patients with lupus in Turkey.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news